Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104007
Filing Date
2025-08-06
Accepted
2025-08-06 16:09:15
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sera-20250630.htm   iXBRL 10-Q 3092112
2 EX-10.1 sera-ex10_1.htm EX-10.1 139807
3 EX-10.2 sera-ex10_2.htm EX-10.2 60551
4 EX-31.1 sera-ex31_1.htm EX-31.1 14975
5 EX-31.2 sera-ex31_2.htm EX-31.2 15006
6 EX-32.1 sera-ex32_1.htm EX-32.1 10679
  Complete submission text file 0000950170-25-104007.txt   12480556

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sera-20250630.xsd EX-101.SCH 1215581
81 EXTRACTED XBRL INSTANCE DOCUMENT sera-20250630_htm.xml XML 2798645
Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Filer) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40606 | Film No.: 251189604
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)